--- Chain 7 for Question 102 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: D
Prompt Tokens (Usage): 439
Completion Tokens (Usage): 4190
Reasoning Tokens (Counted): 3701
Non-Reasoning Tokens (Counted): 487
Total Tokens (Usage): N/A

--- Reasoning Content ---
Okay, so I've got this pretty complicated question here about a biological experiment involving genetic constructs and fluorescent markers. Let me try to break it down step by step to figure out what's going on.

First, the setup: The question is about a ligand-receptor pair expressed in neural crest cells. The goal is to understand their developmental fate. So the experiment involves creating a bicistronic vector with these two genes. Bicistronic means the vector carries two genes under a single promoter, right? So the vector has the ligand ORF (open reading frame) at the 5' end and the receptor ORF at the 3' end. They're using loxP and lox2272 stop cassettes to control expression.

Wait, the ligand is under the CBA promoter. CBA is a strong promoter, I think. Then, upstream of the receptor is an IRES element. I remember that IRES elements allow internal ribosome entry, which can drive the translation of a downstream ORF, even in the presence of a stop codon upstream. So, the ligand is expressed from the CBA promoter, and the receptor might be expressed via IRES, which would allow both proteins to be made from the same transcript but independently.

The vector is bicistronic with loxP and lox2272. So, the ligand is fused to mCherry, and the receptor has eGFP at the C-terminus. The stop cassettes are between the ligand and mCherry (loxP) and between the receptor and eGFP (lox2272).

Wait, the construct: The ligand is in the 5' position, so transcription starts, the ligand is expressed, then the stop with loxP, then mCherry. Then, IRES for the receptor, which is followed by another stop cassette (lox2272), then eGFP.

But when the Cre recombinase acts, it would remove the stop cassettes. So in the presence of Cre, the stop in front of mCherry would be removed, allowing mCherry to be expressed along with the ligand. Similarly, the stop in front of eGFP would be removed, letting eGFP be expressed with the receptor.

So the setup is designed so that in cells where Cre is active, both the ligand and receptor will be expressed along with their respective fluorescent tags.

But the experiment goes as follows: They transfected the plasmid into primary astrocyte cultures and used the antibodies against the overexpressed proteins to test expression via Western blot. The blot shows signals proportional to actin loading, which suggests that the loading and detection are working correctly. So the proteins are being expressed, but then when they make a mouse model homozygous for the construct in a wild-type background, they cross it with SOX10-Cre hemizygous mice. After the offspring are born, they look under the confocal microscope for green signal (from eGFP) but don't see it.

Hmm. So the problem is that the eGFP isn't being expressed. Why?

Looking at the options:

Option A: ligand and receptor are in a paracrine relationship. Paracrine means they act on nearby cells. But if the ligand and receptor are both expressed in the same cells (since the construct is bicistronic), then they would be autocrine or endocrine. But if they're in a paracrine relationship, perhaps they're secreted and act on other cells. But the question is about the expression of the GFP, not the function of the ligand-receptor pair.

Option B: the receptor-eGFP construct is stuck in the Golgi. That would prevent proper trafficking to the cell membrane, so the eGFP wouldn't be visible under the microscope. But why would the Cre mouse cause this? I'm not sure. Also, the Western blot would detect the protein regardless of its location, as it's a total protein extract. Unless the construct isn't properly processed, but the question says the Western blot detected signals proportional to actin, meaning the proteins are made.

Option C: the enhancer for the ligand and receptor expression is missing. Wait, the ligand is under the CBA promoter, which is a strong constitutive promoter. The receptor is under IRES, which depends on the translation machinery. So if there's no enhancer, perhaps the ligand isn't expressed? But the Western blot showed the proteins, so the promoters are working. Unless the enhancer is needed for tissue-specific expression, but the initial construct was transfected into astrocytes, and they saw expression. So maybe the enhancer is not the issue here.

Option D: the receptor and the eGFP are not in the frame. Oh, right, if the ORF is not in frame, the eGFP won't be correctly translated. So the eGFP would be expressed as a separate peptide but if it's out of frame, perhaps it's not functional. Wait, but in the construct, the receptor is at the 3' end, followed by the stop and then eGFP. Wait, no, the sequence is ligand ORF, then stop, then mCherry. Then IRES, receptor ORF, stop, eGFP.

Wait, no, the way the construct is set up is that the ligand is first, then a stop cassette (loxP-stop-loxP), so when Cre is present, the stop is removed, and mCherry is expressed in frame with the ligand. Similarly, the receptor is under IRES, so when the IRES is active, the receptor is translated, and then after a stop, eGFP is present. Wait, but the eGFP is after the stop and lox2272 cassette. So the construct would be: [CBA promoter] --> ligand ORF --> loxP-stop --> mCherry --> IRES --> receptor ORF --> lox2272-stop --> eGFP.

Wait, no. Let me think again. The vector is bicistronic, so the transcript is from the CBA promoter, containing both the ligand and receptor ORFs. The ligand is in the 5' part, and the receptor in the 3' part. Between them is the IRES, perhaps. Wait, the question says, "the ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element." Hmm, that's a bit confusing. Maybe the CBA promoter drives the ligand, and the IRES is before the receptor, meaning that the receptor is expressed as a separate ORF via the IRES. So the transcript would have the ligand followed by the IRES, then the receptor. So the construct would be:

Promoter --> ligand ORF --> IRES --> receptor ORF --> stop --> eGFP.

But then there are stop cassettes. So the ligand is followed by a loxP-stop, and between the receptor and eGFP is the lox2272-stop.

Wait, the problem states:

- Ligand ORF at 5', fused to mCherry; between ligand and mCherry is a loxP-stop-loxP cassette.

- Receptor ORF at 3', fused to eGFP; between receptor and eGFP is a lox2272-stop-lox2272 cassette.

So the transcript would be:

Promoter (maybe CBA?) --> ligand ORF --> loxP-stop --> mCherry ORF --> IRES element --> receptor ORF --> lox2272-stop --> eGFP ORF.

Wait, but the CBA promoter is only for the ligand? Or is the entire transcript under CBA? Hmm, maybe the CBA promoter is driving the entire bicistronic transcript, which includes both ligand and receptor.

But when the vector is transfected, the cells express both ligand and receptor, perhaps. But without Cre, the stop cassettes would prevent mCherry and eGFP from being expressed because the stop codons are in the way.

But when Cre is present, it would remove the loxP and lox2272 cassettes, allowing mCherry to be expressed with the ligand and eGFP with the receptor.

Wait, but in the Western blot, the researchers used antibodies against the overexpressed proteins (I assume the ligand and receptor) and saw signals proportional to actin. That suggests that the ligand and receptor are being expressed, but perhaps the fluorescent tags aren't. Because the Western blot would detect the ligand and receptor, not the fluorescent proteins, unless the antibodies are against them.

So when the mouse model is homozygous for the construct and crossed with SOX10-Cre, the Cre would excise the stop cassettes in the cells expressing SOX10 (neural crest derivatives, like astrocytes maybe). So in those cells, the ligand and mCherry would be expressed together, and the receptor and eGFP would be expressed together.

But when they looked under the confocal, they didn't see the green signal (eGFP). So the eGFP isn't being expressed, or it's not fluorescent for some other reason.

Looking at the options, option D is that the receptor and eGFP are not in the same reading frame. So perhaps the construct after the stop cassette and Cre recombination is not in frame with the receptor, leading to eGFP being not expressed correctly.

Wait, the construct for the receptor is as follows: after the IRES, the receptor ORF is present. Then a stop cassette (loxP2272), then eGFP. So when Cre removes the stop, the receptor ORF is followed directly by eGFP. If the stop cassette is removed, but the eGFP is not in frame, then the eGFP would not be expressed as a fusion protein. Or maybe the eGFP is in frame but not correctly, leading to a frameshift.

Wait, but I'm a bit confused about how the stop cassettes are arranged. The loxP and lox2272 are different sites for Cre, so they can be used in a way that allows for sequential recombination or independent ones.

Wait, another possibility: the IRES is after the ligand, so the transcript is ligand, then IRES, then receptor. The ligand is followed by a loxP-stop, so without Cre, mCherry isn't expressed. The receptor has a lox2272 stop, so without Cre, eGFP isn't expressed.

But in the mouse model, they crossed it with SOX10-Cre, which should express Cre in neural crest-derived cells. So in those cells, the stop cassettes would be removed. So the ligand would be expressed with mCherry, and the receptor with eGFP.

But perhaps the eGFP isn't being expressed because the stop cassette wasn't properly removed, or the construct wasn't correctly recombined.

Wait, but the Western blot showed that the proteins are expressed. So the ligand and receptor are being made. So the problem isn't with the expression of the receptors themselves, but the fluorescent tags.

If the eGFP isn't being expressed, perhaps the stop cassette wasn't excised. But why would that happen? Well, perhaps the Cre isn't active in the cells, or the construct isn't getting recombined.

Wait, but the mouse model is homozygous for the construct, and they crossed it with SOX10-Cre. SOX10 is expressed in neural crest cells and their derivatives, so the Cre should be active in those cells, which would excise the stop cassettes.

Alternatively, perhaps the Cre is not working properly, but the question says they used the SOX10-Cre mice. SOX10 is a good Cre driver in these cells, so that's probably not the issue.

Another possibility is that the eGFP is not in frame. If the lox2272 cassette is not correctly flanking the stop, then when Cre removes it, the eGFP might not be in frame with the receptor.

Wait, let's think about the cloning. The receptor ORF is followed by a stop codon, then lox2272, then another stop, then eGFP? Or is the eGFP in-frame with the receptor?

Suppose the construct is:

[Receptor ORF] --- stop --- [lox2272] --- stop --- [eGFP]

When Cre is present, it removes the lox2272 and the stop, so the receptor ORF is directly followed by eGFP. If the stop was in frame, then the eGFP might not be in frame. Or perhaps the eGFP is in a different reading frame, so when the stop is removed, the eGFP isn't correctly incorporated.

Wait, in the vector, the stop is in a lox2272 cassette. So the sequence after the receptor ORF is stop, then the lox2272. So when Cre cuts, it removes the stop and the lox2272. So the receptor ORF would be spliced directly to the eGFP. But if the eGFP is not in frame, perhaps the reading frame is disrupted, leading to a premature stop or no eGFP expression.

Alternatively, perhaps the stop is in the same frame as the receptor, so when it's removed, the eGFP is in frame but as a separate ORF. So during translation, when the stop is removed, the ribosome would continue into eGFP. But if the eGFP is in the same frame, it would be expressed as a fusion, but if it's not, perhaps not.

Wait, but the construct would have the receptor ORF, then a stop, then lox2272, then another stop, then eGFP. So after Cre recombination, the receptor ORF is directly connected to eGFP. But the stop codons and the lox sites are in the DNA. So if the eGFP is in frame, it would be expressed as a C-terminal tag. If it's not in frame, perhaps it's not expressed.

So if the eGFP is not in frame, the translation would stop at the stop codon, and eGFP wouldn't be made. But the Western blot was done with antibodies against the overexpressed proteins (ligand and receptor), so that's okay.

Wait, but the question states that the Western blot detects the proteins proportional to actin. So the ligand and receptor are being expressed. So the problem is that the eGFP isn't being expressed, but the receptor is.

So why wouldn't the eGFP be expressed? If the lox2272 stop wasn't correctly excised, the stop remains, preventing eGFP expression. But why would the stop not be excised?

Alternatively, perhaps the IRES isn't working, so the receptor isn't being translated. But the Western blot shows the receptor is expressed, so the IRES is working.

Wait, but the IRES is upstream of the receptor. So the ligand is under the CBA promoter, and the receptor is under the IRES. So the same transcript would have the ligand and receptor. So with Cre, the ligand and mCherry are expressed together, and the receptor and eGFP together.

But perhaps the issue is that the eGFP is not in frame, so when the stop is removed, the frame is shifted.

Another angle: the constructs are designed such that when Cre is present, the stop cassettes are removed. But the eGFP may be in the same reading frame as the receptor. If the construct is not in frame, the eGFP would not be expressed.

Wait, the question states that the ligand and receptor ORFs are each fused to mCherry and eGFP. So the ligand is translated into ligand-mCherry, and the receptor is translated into receptor-eGFP.

If the stop cassettes are properly removed, then the eGFP should be expressed. So the reason for no signal is likely that the eGFP isn't being made. But why?

Looking at the options again:

Option D: the receptor and eGFP are not in the frame. So, when the stop cassette is removed, the eGFP isn't in frame, so it's not expressed as a separate protein.

But the Western blot detects the receptor. So the receptor is being made, but the eGFP isn't. So perhaps the eGFP is in a different frame, so it's not being translated.

So the correct answer would be D: the receptor and eGFP are not in the same frame, leading to eGFP not being expressed, hence no green signal.

Wait, but the eGFP is fused to the receptor. If the eGFP is not in frame, then the C-terminal part of the receptor may not be correctly translated, but the Western blot detected the receptor. Hmm, but the Western blot uses antibodies against the overexpressed proteins, which would be the ligand and receptor. So even if the eGFP is not expressed, the receptor would still be expressed, which is the case.

So the issue is eGFP, not the receptor.

So the most likely reason is that the eGFP is not in frame, thus not expressed. So the answer is D.


--- Final Answer Content ---


The question involves a bicistronic lox-Cre vector expressing a ligand and receptor, with fluorescent tags mCherry and eGFP fused to the ligand and receptor, respectively. The ligand is under the CBA promoter, and the receptor is under an IRES regulatory element. Stop cassettes (loxP-stop-loxP and lox2272-stop-lox2272) are used to control the expression of the fluorescent tags. After transfecting the construct into primary astrocytes, Western blot confirms that the ligand and receptor are expressed, as their signals are proportional to actin loading. However, when the mouse model homozygous for the construct is crossed with SOX10-Cre mice, no green signal (from eGFP) is observed under confocal microscopy.

### Key Analysis of Options:
- **Option A**: The ligand and receptor being in a paracrine relationship pertains to their functional interaction, not the expression of eGFP. The question focuses on the lack of fluorescence, so this option is irrelevant.
- **Option B**: If the receptor-eGFP construct were stuck in the Golgi, it would prevent proper trafficking to the cell membrane, but the Western blot detects the receptor, indicating that it is being synthesized. Thus, this is unlikely to explain the lack of eGFP signal.
- **Option C**: The CBA promoter is a strong constitutive promoter, and the IRES element ensures translation of the receptor. The Western blot confirms that both the ligand and receptor are expressed, so the enhancer is not the issue.
- **Option D**: The eGFP is fused to the receptor, and its expression depends on proper removal of the lox2272-stop cassette by Cre recombinase. If the eGFP is not in the same reading frame as the receptor, it would not be translated correctly. This would result in the receptor being expressed (detected by Western blot) but eGFP not being expressed, consistent with the observed lack of green fluorescence.

### Conclusion:
The most likely explanation is that the eGFP is not in the same reading frame as the receptor, preventing its expression. This aligns with the observation that the receptor is expressed (detected by Western blot) but no green signal is seen under confocal microscopy.

Answer: D

--- Full Content ---
Okay, so I've got this pretty complicated question here about a biological experiment involving genetic constructs and fluorescent markers. Let me try to break it down step by step to figure out what's going on.

First, the setup: The question is about a ligand-receptor pair expressed in neural crest cells. The goal is to understand their developmental fate. So the experiment involves creating a bicistronic vector with these two genes. Bicistronic means the vector carries two genes under a single promoter, right? So the vector has the ligand ORF (open reading frame) at the 5' end and the receptor ORF at the 3' end. They're using loxP and lox2272 stop cassettes to control expression.

Wait, the ligand is under the CBA promoter. CBA is a strong promoter, I think. Then, upstream of the receptor is an IRES element. I remember that IRES elements allow internal ribosome entry, which can drive the translation of a downstream ORF, even in the presence of a stop codon upstream. So, the ligand is expressed from the CBA promoter, and the receptor might be expressed via IRES, which would allow both proteins to be made from the same transcript but independently.

The vector is bicistronic with loxP and lox2272. So, the ligand is fused to mCherry, and the receptor has eGFP at the C-terminus. The stop cassettes are between the ligand and mCherry (loxP) and between the receptor and eGFP (lox2272).

Wait, the construct: The ligand is in the 5' position, so transcription starts, the ligand is expressed, then the stop with loxP, then mCherry. Then, IRES for the receptor, which is followed by another stop cassette (lox2272), then eGFP.

But when the Cre recombinase acts, it would remove the stop cassettes. So in the presence of Cre, the stop in front of mCherry would be removed, allowing mCherry to be expressed along with the ligand. Similarly, the stop in front of eGFP would be removed, letting eGFP be expressed with the receptor.

So the setup is designed so that in cells where Cre is active, both the ligand and receptor will be expressed along with their respective fluorescent tags.

But the experiment goes as follows: They transfected the plasmid into primary astrocyte cultures and used the antibodies against the overexpressed proteins to test expression via Western blot. The blot shows signals proportional to actin loading, which suggests that the loading and detection are working correctly. So the proteins are being expressed, but then when they make a mouse model homozygous for the construct in a wild-type background, they cross it with SOX10-Cre hemizygous mice. After the offspring are born, they look under the confocal microscope for green signal (from eGFP) but don't see it.

Hmm. So the problem is that the eGFP isn't being expressed. Why?

Looking at the options:

Option A: ligand and receptor are in a paracrine relationship. Paracrine means they act on nearby cells. But if the ligand and receptor are both expressed in the same cells (since the construct is bicistronic), then they would be autocrine or endocrine. But if they're in a paracrine relationship, perhaps they're secreted and act on other cells. But the question is about the expression of the GFP, not the function of the ligand-receptor pair.

Option B: the receptor-eGFP construct is stuck in the Golgi. That would prevent proper trafficking to the cell membrane, so the eGFP wouldn't be visible under the microscope. But why would the Cre mouse cause this? I'm not sure. Also, the Western blot would detect the protein regardless of its location, as it's a total protein extract. Unless the construct isn't properly processed, but the question says the Western blot detected signals proportional to actin, meaning the proteins are made.

Option C: the enhancer for the ligand and receptor expression is missing. Wait, the ligand is under the CBA promoter, which is a strong constitutive promoter. The receptor is under IRES, which depends on the translation machinery. So if there's no enhancer, perhaps the ligand isn't expressed? But the Western blot showed the proteins, so the promoters are working. Unless the enhancer is needed for tissue-specific expression, but the initial construct was transfected into astrocytes, and they saw expression. So maybe the enhancer is not the issue here.

Option D: the receptor and the eGFP are not in the frame. Oh, right, if the ORF is not in frame, the eGFP won't be correctly translated. So the eGFP would be expressed as a separate peptide but if it's out of frame, perhaps it's not functional. Wait, but in the construct, the receptor is at the 3' end, followed by the stop and then eGFP. Wait, no, the sequence is ligand ORF, then stop, then mCherry. Then IRES, receptor ORF, stop, eGFP.

Wait, no, the way the construct is set up is that the ligand is first, then a stop cassette (loxP-stop-loxP), so when Cre is present, the stop is removed, and mCherry is expressed in frame with the ligand. Similarly, the receptor is under IRES, so when the IRES is active, the receptor is translated, and then after a stop, eGFP is present. Wait, but the eGFP is after the stop and lox2272 cassette. So the construct would be: [CBA promoter] --> ligand ORF --> loxP-stop --> mCherry --> IRES --> receptor ORF --> lox2272-stop --> eGFP.

Wait, no. Let me think again. The vector is bicistronic, so the transcript is from the CBA promoter, containing both the ligand and receptor ORFs. The ligand is in the 5' part, and the receptor in the 3' part. Between them is the IRES, perhaps. Wait, the question says, "the ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element." Hmm, that's a bit confusing. Maybe the CBA promoter drives the ligand, and the IRES is before the receptor, meaning that the receptor is expressed as a separate ORF via the IRES. So the transcript would have the ligand followed by the IRES, then the receptor. So the construct would be:

Promoter --> ligand ORF --> IRES --> receptor ORF --> stop --> eGFP.

But then there are stop cassettes. So the ligand is followed by a loxP-stop, and between the receptor and eGFP is the lox2272-stop.

Wait, the problem states:

- Ligand ORF at 5', fused to mCherry; between ligand and mCherry is a loxP-stop-loxP cassette.

- Receptor ORF at 3', fused to eGFP; between receptor and eGFP is a lox2272-stop-lox2272 cassette.

So the transcript would be:

Promoter (maybe CBA?) --> ligand ORF --> loxP-stop --> mCherry ORF --> IRES element --> receptor ORF --> lox2272-stop --> eGFP ORF.

Wait, but the CBA promoter is only for the ligand? Or is the entire transcript under CBA? Hmm, maybe the CBA promoter is driving the entire bicistronic transcript, which includes both ligand and receptor.

But when the vector is transfected, the cells express both ligand and receptor, perhaps. But without Cre, the stop cassettes would prevent mCherry and eGFP from being expressed because the stop codons are in the way.

But when Cre is present, it would remove the loxP and lox2272 cassettes, allowing mCherry to be expressed with the ligand and eGFP with the receptor.

Wait, but in the Western blot, the researchers used antibodies against the overexpressed proteins (I assume the ligand and receptor) and saw signals proportional to actin. That suggests that the ligand and receptor are being expressed, but perhaps the fluorescent tags aren't. Because the Western blot would detect the ligand and receptor, not the fluorescent proteins, unless the antibodies are against them.

So when the mouse model is homozygous for the construct and crossed with SOX10-Cre, the Cre would excise the stop cassettes in the cells expressing SOX10 (neural crest derivatives, like astrocytes maybe). So in those cells, the ligand and mCherry would be expressed together, and the receptor and eGFP would be expressed together.

But when they looked under the confocal, they didn't see the green signal (eGFP). So the eGFP isn't being expressed, or it's not fluorescent for some other reason.

Looking at the options, option D is that the receptor and eGFP are not in the same reading frame. So perhaps the construct after the stop cassette and Cre recombination is not in frame with the receptor, leading to eGFP being not expressed correctly.

Wait, the construct for the receptor is as follows: after the IRES, the receptor ORF is present. Then a stop cassette (loxP2272), then eGFP. So when Cre removes the stop, the receptor ORF is followed directly by eGFP. If the stop cassette is removed, but the eGFP is not in frame, then the eGFP would not be expressed as a fusion protein. Or maybe the eGFP is in frame but not correctly, leading to a frameshift.

Wait, but I'm a bit confused about how the stop cassettes are arranged. The loxP and lox2272 are different sites for Cre, so they can be used in a way that allows for sequential recombination or independent ones.

Wait, another possibility: the IRES is after the ligand, so the transcript is ligand, then IRES, then receptor. The ligand is followed by a loxP-stop, so without Cre, mCherry isn't expressed. The receptor has a lox2272 stop, so without Cre, eGFP isn't expressed.

But in the mouse model, they crossed it with SOX10-Cre, which should express Cre in neural crest-derived cells. So in those cells, the stop cassettes would be removed. So the ligand would be expressed with mCherry, and the receptor with eGFP.

But perhaps the eGFP isn't being expressed because the stop cassette wasn't properly removed, or the construct wasn't correctly recombined.

Wait, but the Western blot showed that the proteins are expressed. So the ligand and receptor are being made. So the problem isn't with the expression of the receptors themselves, but the fluorescent tags.

If the eGFP isn't being expressed, perhaps the stop cassette wasn't excised. But why would that happen? Well, perhaps the Cre isn't active in the cells, or the construct isn't getting recombined.

Wait, but the mouse model is homozygous for the construct, and they crossed it with SOX10-Cre. SOX10 is expressed in neural crest cells and their derivatives, so the Cre should be active in those cells, which would excise the stop cassettes.

Alternatively, perhaps the Cre is not working properly, but the question says they used the SOX10-Cre mice. SOX10 is a good Cre driver in these cells, so that's probably not the issue.

Another possibility is that the eGFP is not in frame. If the lox2272 cassette is not correctly flanking the stop, then when Cre removes it, the eGFP might not be in frame with the receptor.

Wait, let's think about the cloning. The receptor ORF is followed by a stop codon, then lox2272, then another stop, then eGFP? Or is the eGFP in-frame with the receptor?

Suppose the construct is:

[Receptor ORF] --- stop --- [lox2272] --- stop --- [eGFP]

When Cre is present, it removes the lox2272 and the stop, so the receptor ORF is directly followed by eGFP. If the stop was in frame, then the eGFP might not be in frame. Or perhaps the eGFP is in a different reading frame, so when the stop is removed, the eGFP isn't correctly incorporated.

Wait, in the vector, the stop is in a lox2272 cassette. So the sequence after the receptor ORF is stop, then the lox2272. So when Cre cuts, it removes the stop and the lox2272. So the receptor ORF would be spliced directly to the eGFP. But if the eGFP is not in frame, perhaps the reading frame is disrupted, leading to a premature stop or no eGFP expression.

Alternatively, perhaps the stop is in the same frame as the receptor, so when it's removed, the eGFP is in frame but as a separate ORF. So during translation, when the stop is removed, the ribosome would continue into eGFP. But if the eGFP is in the same frame, it would be expressed as a fusion, but if it's not, perhaps not.

Wait, but the construct would have the receptor ORF, then a stop, then lox2272, then another stop, then eGFP. So after Cre recombination, the receptor ORF is directly connected to eGFP. But the stop codons and the lox sites are in the DNA. So if the eGFP is in frame, it would be expressed as a C-terminal tag. If it's not in frame, perhaps it's not expressed.

So if the eGFP is not in frame, the translation would stop at the stop codon, and eGFP wouldn't be made. But the Western blot was done with antibodies against the overexpressed proteins (ligand and receptor), so that's okay.

Wait, but the question states that the Western blot detects the proteins proportional to actin. So the ligand and receptor are being expressed. So the problem is that the eGFP isn't being expressed, but the receptor is.

So why wouldn't the eGFP be expressed? If the lox2272 stop wasn't correctly excised, the stop remains, preventing eGFP expression. But why would the stop not be excised?

Alternatively, perhaps the IRES isn't working, so the receptor isn't being translated. But the Western blot shows the receptor is expressed, so the IRES is working.

Wait, but the IRES is upstream of the receptor. So the ligand is under the CBA promoter, and the receptor is under the IRES. So the same transcript would have the ligand and receptor. So with Cre, the ligand and mCherry are expressed together, and the receptor and eGFP together.

But perhaps the issue is that the eGFP is not in frame, so when the stop is removed, the frame is shifted.

Another angle: the constructs are designed such that when Cre is present, the stop cassettes are removed. But the eGFP may be in the same reading frame as the receptor. If the construct is not in frame, the eGFP would not be expressed.

Wait, the question states that the ligand and receptor ORFs are each fused to mCherry and eGFP. So the ligand is translated into ligand-mCherry, and the receptor is translated into receptor-eGFP.

If the stop cassettes are properly removed, then the eGFP should be expressed. So the reason for no signal is likely that the eGFP isn't being made. But why?

Looking at the options again:

Option D: the receptor and eGFP are not in the frame. So, when the stop cassette is removed, the eGFP isn't in frame, so it's not expressed as a separate protein.

But the Western blot detects the receptor. So the receptor is being made, but the eGFP isn't. So perhaps the eGFP is in a different frame, so it's not being translated.

So the correct answer would be D: the receptor and eGFP are not in the same frame, leading to eGFP not being expressed, hence no green signal.

Wait, but the eGFP is fused to the receptor. If the eGFP is not in frame, then the C-terminal part of the receptor may not be correctly translated, but the Western blot detected the receptor. Hmm, but the Western blot uses antibodies against the overexpressed proteins, which would be the ligand and receptor. So even if the eGFP is not expressed, the receptor would still be expressed, which is the case.

So the issue is eGFP, not the receptor.

So the most likely reason is that the eGFP is not in frame, thus not expressed. So the answer is D.


The question involves a bicistronic lox-Cre vector expressing a ligand and receptor, with fluorescent tags mCherry and eGFP fused to the ligand and receptor, respectively. The ligand is under the CBA promoter, and the receptor is under an IRES regulatory element. Stop cassettes (loxP-stop-loxP and lox2272-stop-lox2272) are used to control the expression of the fluorescent tags. After transfecting the construct into primary astrocytes, Western blot confirms that the ligand and receptor are expressed, as their signals are proportional to actin loading. However, when the mouse model homozygous for the construct is crossed with SOX10-Cre mice, no green signal (from eGFP) is observed under confocal microscopy.

### Key Analysis of Options:
- **Option A**: The ligand and receptor being in a paracrine relationship pertains to their functional interaction, not the expression of eGFP. The question focuses on the lack of fluorescence, so this option is irrelevant.
- **Option B**: If the receptor-eGFP construct were stuck in the Golgi, it would prevent proper trafficking to the cell membrane, but the Western blot detects the receptor, indicating that it is being synthesized. Thus, this is unlikely to explain the lack of eGFP signal.
- **Option C**: The CBA promoter is a strong constitutive promoter, and the IRES element ensures translation of the receptor. The Western blot confirms that both the ligand and receptor are expressed, so the enhancer is not the issue.
- **Option D**: The eGFP is fused to the receptor, and its expression depends on proper removal of the lox2272-stop cassette by Cre recombinase. If the eGFP is not in the same reading frame as the receptor, it would not be translated correctly. This would result in the receptor being expressed (detected by Western blot) but eGFP not being expressed, consistent with the observed lack of green fluorescence.

### Conclusion:
The most likely explanation is that the eGFP is not in the same reading frame as the receptor, preventing its expression. This aligns with the observation that the receptor is expressed (detected by Western blot) but no green signal is seen under confocal microscopy.

Answer: D